Article Information
PubMed
Published By
History
- Received August 24, 2010
- Revision received December 20, 2010
- Accepted January 17, 2011
- First published April 20, 2011.
- Version of record published April 20, 2011.
Copyright & Usage
Copyright © 2011 the authors 0270-6474/11/315970-07$15.00/0
Author Information
- Philip Seibler1,2,
- John Graziotto1,
- Hyun Jeong1,
- Filip Simunovic1,3,
- Christine Klein2, and
- Dimitri Krainc1
- 1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Charlestown, Massachusetts 02129,
- 2Section of Clinical and Molecular Neurogenetics at the Department of Neurology, University of Lübeck, 23562 Lübeck, Germany, and
- 3Mediterranean Institute for Life Sciences, Split 21000, Croatia
Author contributions
Disclosures
- Received August 24, 2010.
- Revision received December 20, 2010.
- Accepted January 17, 2011.
This work was supported by R01NS051303 (D.K.), the German Academic Exchange Service (P.S.), and the Fritz Thyssen Foundation (C.K.). C.K. is a recipient of a career development award from the Volkswagen Foundation and from the Hermann and Lilly Schilling Foundation. We thank George Daley (Children's Hospital, Boston, MA) for providing retroviral reprogramming constructs, Laurence Daheron (Massachusetts General Hospital, Boston, MA) for helpful discussions and experimental advice, and Stuart Chambers and Lorenz Studer (Sloan-Kettering Institute, New York, NY) for helpful technical advice.
- Correspondence should be addressed to Dr. Dimitri Krainc, Massachusetts General Hospital, 114 16th Street, Room 2008, Charlestown, MA 02129. krainc{at}helix.mgh.harvard.edu or dkrainc{at}partners.org
Online Impact